193 related articles for article (PubMed ID: 28526805)
1. Evaluation of crescent formation as a predictive marker in immunoglobulin A nephropathy: a systematic review and meta-analysis.
Shao X; Li B; Cao L; Liang L; Yang J; Wang Y; Feng S; Wang C; Weng C; Shen X; Jiang H; Chen J
Oncotarget; 2017 Jul; 8(28):46436-46448. PubMed ID: 28526805
[TBL] [Abstract][Full Text] [Related]
2. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
[TBL] [Abstract][Full Text] [Related]
4. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histological differences between adults and children in new onset IgA nephropathy.
Cambier A; Rabant M; El Karoui K; Peuchmaur M; Servais A; Hertig A; Deschenes G; Salomon R; Hogan J; Robert T
Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925
[TBL] [Abstract][Full Text] [Related]
6. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
[TBL] [Abstract][Full Text] [Related]
9. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C
Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110
[TBL] [Abstract][Full Text] [Related]
10. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Oxford classification of IgA nephropathy.
Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC
Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X
Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
[TBL] [Abstract][Full Text] [Related]
13. [The effect of endocapillary hypercellularity lesions on the renal prognosis and response to immunosuppressive therapy in IgA nephropathy].
Yang HY; Shi SF; Wang SX; Lyu JC; Zhang H
Zhonghua Nei Ke Za Zhi; 2020 Nov; 59(11):894-897. PubMed ID: 33120494
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.
Puapatanakul P; Banjongjit A; Kanjanabuch T; Surintrspanont J; Iampenkhae K; Praditpornsilpa K; Eiam-Ong S; Boonpucknavig V
Am J Nephrol; 2023; 54(7-8):308-318. PubMed ID: 37429271
[TBL] [Abstract][Full Text] [Related]
15. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
[TBL] [Abstract][Full Text] [Related]
17. The Significance of Crescents on the Clinical Features and Outcomes of Primary Immunoglobin A Nephropathy.
Du Y; Chen S; Wang F; Zhang P; Liu M; Liu C; Zhong X; Qin J; Li G; Wang W
Front Med (Lausanne); 2022; 9():864667. PubMed ID: 35847826
[TBL] [Abstract][Full Text] [Related]
18. IgA nephropathy: an update.
Soares MF; Roberts IS
Curr Opin Nephrol Hypertens; 2017 May; 26(3):165-171. PubMed ID: 28221174
[TBL] [Abstract][Full Text] [Related]
19. Validity of the Oxford classification of IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Togawa H; Hashimura Y; Kaito H; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2012 May; 27(5):783-92. PubMed ID: 22134880
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
